Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Biol Sci ; 16(5): 815-826, 2020.
Article in English | MEDLINE | ID: mdl-32071551

ABSTRACT

Colorectal cancer (CRC) is the second leading cause of death globally. Integrin α1 (ITGA1) belongs to integrin family and involves in regulating cell adhesion, invasion, proliferation and tumorigenicity, its expression is up-regulated in various cancers, including CRC. However, the molecular understanding and clinical relevance of ITGA1 in the development and progression of CRC remain unclear. In the present study, we detected ITGA1 in 50 CRC tissues and adjacent non-cancerous tissues, sera from 100 CRC patients and 50 healthy subjects, and four CRC cell lines using immunohistochemistry staining, enzyme-linked immunosorbent assay and Western blotting. We found that the ITGA1 protein was significantly higher in human CRC tissues and cell lines than both paired non-tumor tissues and normal cells, respectively. In addition, the serum concentration of ITGA1 was also higher in CRC patients compared to the healthy subjects (p<0.01) and was significantly associated with metastatic TNM stages (p<0.0001) and circulating carbohydrate antigen 199 (CA199) (p<0.022). Furthermore, down-regulation of ITGA1 with transfecting LV-shITGA1 inhibited the progressive capacity of cell migration and invasion in CRC SW480 cell line and the tumorgenicity in nude mice. In functional studies, ITGA1 knockdown also inhibited Ras/ERK signaling pathway by decreasing the expression of Ras, p-Erk1/2 and c-Myc in SW480. Contrastly, when evelated expression of ITGA1 in NCM460 coincided with the increased expression of Ras, p-Erk1/2 and c-Myc. Taken together, our findings suggest that ITGA1 is an oncogene with a capability to promote CRC cell migration, invasion and tumorigenicity by activating the Ras/Erk signaling, implying that it may be a novel target for the diagnosis and treatment of CRC, and warrants further investigation.


Subject(s)
Biomarkers, Tumor/blood , Biomarkers, Tumor/metabolism , Colorectal Neoplasms/blood , Colorectal Neoplasms/pathology , Integrin alpha1/blood , Integrin alpha1/metabolism , Animals , Cell Line, Tumor , Cell Movement/genetics , Cell Movement/physiology , Colorectal Neoplasms/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Regulation, Neoplastic , HCT116 Cells , HT29 Cells , Humans , Immunoblotting , Immunohistochemistry , Mice , Mice, Nude
2.
Pharmaceutics ; 11(2)2019 Jan 25.
Article in English | MEDLINE | ID: mdl-30691070

ABSTRACT

Icariin (ICA) is a major flavonoid that contains the active compound Epimedii Folium. However, ICA's pharmacokinetic characteristics remain unsatisfactory due to its low bioavailability, and hence limited drugability. In order to improve its pharmacokinetics and achieve prolonged blood circulation time, a novel polymeric micelle, made of the self-assembled micelle between poly (ethylene glycol)-poly (L-lactic acid) (PEG-PLLA) and poly (D-lactic acid)-poly(N-isopropylacrylamide) (PDLA-PNIPAM), was designed to encapsulate ICA. Our experimental results showed that this polymeric micelle formulation of ICA exhibited uniform nano-size distribution and high stability within 48 h. The new formulation also allowed sustained ICA release in an in vitro drug release study. Furthermore, in vivo experiments revealed that ICA bioavailability in the PEG-PLLA/PDLA-PNIPAM polymeric micelle formulation was significantly higher compared to ICA alone, or ICA in the traditional Pluronic F127 micelle formulation. Finally, we show that metabolite analysis confirmed that ICA within the PEG-PLLA/PDLA-PNIPAM polymeric micelle formulation provided better drug protection, reduced drug metabolites production, and decreased undesired first-pass effects. Overall, these data show that ICA within PEG-PLLA/PDLA-PNIPAM polymeric micelle formulation exhibit advantages, in terms of improved physicochemical properties, sustained release of ICA in vitro, and improved bioavailability of ICA in vivo, which represent a feasible approach for improving the drugability of pharmaceutical small molecules with low bioavailability or poor stability.

3.
J Cell Physiol ; 234(1): 709-720, 2018 01.
Article in English | MEDLINE | ID: mdl-30069867

ABSTRACT

Progesterone receptor membrane component 1 (PGRMC1) mediates antimitotic and antiapoptotic actions of progesterone in granulosa cells, which indicates that PGRMC1 may play a key role in maintaining the status of granulosa cells. The current study investigated the effects of progesterone on intracellular signaling involved in differentiation, follicle development, inflammatory responses, and antioxidation, and determined the role of PGRMC1 in these processes. Our results demonstrated that progesterone slowed follicle development and inhibited p-ERK1/2, p-p38, caspase-3, p-NF-κB, and p-IκB-α signals involved in differentiation, steroidogenesis, and inflammatory responses in granulosa cells. Progesterone inhibited the steroidogenic acute regulatory protein and the cholesterol side-chain cleavage enzyme and decreased pregnenolone production. A PGRMC1 inhibitor and a PGRMC1 small interfering RNA ablated these inhibitory effects of progesterone. Interfering with PGRMC1 functions also decreased cellular antioxidative effects induced by an oxidant. These results suggest that PGRMC1 might play a critical role in maintaining the status of granulosa cells and balancing follicle numbers.


Subject(s)
Granulosa Cells/cytology , Membrane Proteins/genetics , Ovarian Follicle/growth & development , Progesterone/metabolism , Receptors, Progesterone/genetics , Apoptosis/genetics , Caspase 3/genetics , Cell Differentiation/genetics , Cells, Cultured , Female , Gene Expression Regulation, Developmental/genetics , Granulosa Cells/metabolism , Humans , Membrane Proteins/antagonists & inhibitors , Ovarian Follicle/metabolism , Receptors, Progesterone/antagonists & inhibitors , Signal Transduction/genetics
4.
J Steroid Biochem Mol Biol ; 155(Pt A): 104-11, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26462682

ABSTRACT

The role of progesterone on the cardiovascular system is controversial. Our present research is to specify the effect of progesterone on arterial endothelial cells in response to oxidative stress. Our result showed that H2O2 (150 µM and 300 µM) induced cellular antioxidant response. Glutathione (GSH) production and the activity of Glutathione peroxidase (GPx) were increased in H2O2-treated group. The expression of glutamate cysteine ligase catalytic subunit (GCLC) and modifier subunit (GCLM) was induced in response to H2O2. However, progesterone absolutely abolished the antioxidant response through increasing ROS level, inhibiting the activity of Glutathione peroxidase (GPx), decreasing GSH level and reducing expression of GClC and GCLM. In our study, H2O2 induced nitrogen monoxide (NO) production and endothelial nitric oxide synthase (eNOS) expression, and progesterone promoted H2O2-induced NO production. Progesterone increased H2O2-induced expression of hypoxia inducible factor-α (HIFα) which in turn regulated eNOS expression and NO synthesis. Further study demonstrated that progesterone increased H2O2 concentration of culture medium which may contribute to NO synthesis. Exogenous GSH decreased the content of H2O2 of culture medium pretreated by progesterone combined with H2O2 or progesterone alone. GSH also inhibited expression of HIFα and eNOS, and abolished NO synthesis. Collectively, our study demonstrated for the first time that progesterone inhibited cellular antioxidant effect and increased oxidative stress, promoted NO production of arterial endothelial cells, which may be due to the increasing H2O2 concentration and amplified oxidative stress signal.


Subject(s)
Endothelium, Vascular/cytology , Hydrogen Peroxide/metabolism , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Progesterone/pharmacology , Animals , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Glutathione/metabolism , Glutathione/pharmacology , Hydrogen Peroxide/pharmacology , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Kidney/drug effects , Kidney/metabolism , Mice , Nitric Oxide Synthase Type III/metabolism , Progesterone/metabolism
5.
Neurol Sci ; 34(6): 941-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22833221

ABSTRACT

In this study the chitosan/collagen/icariin composite scaffolds for nerve regeneration were produced by blending and crosslinking chitosan with collagen and icariin. The microstructure of the composite scaffolds was observed by scanning electron microscopy. 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide and attachment assays were conducted, respectively, to investigate the biocompatibility of the scaffolds. Cell cultural tests showed that the channel-structured porous scaffolds acted as a positive factor to support connective nerve cell growth. After culture, cells showed a clear flow trend to move close to the composite scaffolds in culture solution, arranging in spiral-like, and aligned parallel to the orientation of the channel structure on the surface of scaffolds. When compared to pure chitosan and chitosan/collagen scaffolds, Schwann cells and PC12 cells on the chitosan/collagen/icariin composite scaffolds exhibited the greatest proliferation and longest average neurite length. These results suggested that the chitosan/collagen/icariin composite scaffolds are potential cell carriers in nerve tissue engineering.


Subject(s)
Cell Enlargement/drug effects , Chitosan/pharmacology , Collagen/pharmacology , Flavonoids/pharmacology , Tissue Scaffolds , Animals , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Chitosan/chemistry , Collagen/chemistry , Flavonoids/chemistry , Mice , Mice, Inbred BALB C , Microscopy, Electron, Scanning , Neurites/drug effects , Neurites/ultrastructure , PC12 Cells , Rats , Schwann Cells/drug effects , Schwann Cells/physiology , Schwann Cells/ultrastructure , Sciatic Nerve/cytology , Time Factors
6.
J Neuroimaging ; 23(1): 105-7, 2013 Jan.
Article in English | MEDLINE | ID: mdl-21815965

ABSTRACT

Partial steal has been regarded as a classic ultrasound appearance of subclavian steal syndrome. We report a case with the vertebral artery origin stenosis and intact subclavian artery, which showed the similar partial steal ultrasound features. The following computerized tomography angiography confirmed the stenosis. Therefore, when an alternating flow in the vertebral artery is detected, the investigation of its origin must be performed besides the ipsilateral subclavian artery.


Subject(s)
Peripheral Arterial Disease/diagnosis , Subclavian Steal Syndrome/diagnosis , Vertebral Artery/diagnostic imaging , Aged , Constriction, Pathologic , Diagnosis, Differential , Female , Humans , Radiography , Ultrasonography
7.
Drug Dev Ind Pharm ; 37(7): 765-74, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21244276

ABSTRACT

Intravenously injectable emulsion of ß-elemene was studied in detail. Both blank and ß-elemene-loaded microemulsions were prepared using a simple water titration method. The pseudoternary phase diagram was constructed for the optimization of microemulsion. The loading capacity test, dilutability test, and especially the influence of antioxidants were conducted for further optimization of ß-elemene-loaded microemulsion. Transmission electron microscope showed intact and spherical microemulsion droplets. Conductivity and viscosity measurements were used to study the phase behaviors of ß-elemene-loaded microemulsions, providing convincing explanation. In vitro release study showed that ß-elemene was steadily released until 12 h, which most fitted the first order.


Subject(s)
Sesquiterpenes/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Antioxidants/administration & dosage , Drug Compounding/methods , Drug Delivery Systems , Electric Conductivity , Emulsions , Humans , In Vitro Techniques , Neoplasms/drug therapy , Particle Size , Viscosity
8.
Zhong Yao Cai ; 34(10): 1483-6, 2011 Oct.
Article in Chinese | MEDLINE | ID: mdl-22372131

ABSTRACT

OBJECTIVE: To study the effect of different treatments on the Valeriana amurensis seed germination rate. METHODS: Used different chemical reagents and seed soakings on the routine germination test and the orthogonal test of the Valeriana amurensis seed, calculated the germination rate under different germination condition. RESULTS: Valeriana amurensis treated with different chemical reagends had different germination rate. The suitable immersion time could enhance Valeriana amurensis seed germination rate. Different treatment time, different disposal temperature, different germination temperature would have an impact on the Valeriana amurensis seed germination rate. CONCLUSION: In order to raise the Valeriana amurensis seed germination rate, use appropriate treatment on the seed before plant seeds; The seed growing must under suitable time and temperature.


Subject(s)
Germination , Plants, Medicinal/growth & development , Seeds/growth & development , Valerian/growth & development , Hydrogen Peroxide/pharmacology , Microwaves , Penicillins/pharmacology , Plants, Medicinal/physiology , Potassium Permanganate/pharmacology , Seeds/drug effects , Seeds/physiology , Temperature , Valerian/drug effects , Valerian/physiology , Water
9.
Chem Pharm Bull (Tokyo) ; 58(5): 656-61, 2010 May.
Article in English | MEDLINE | ID: mdl-20460792

ABSTRACT

The objective of the present work was to study the preparation, optimization and characteristics of Huperzine A (Hup A), an effective Traditional Chinese Medicine treatment of Alzheimer's disease (AD), loaded nanostructured lipid carriers (NLC). NLC were successfully prepared by a modified method of melt ultrasonication followed by high pressure homogenization using Cetyl Palmitate (CP) as the solid lipid, Miglyol((R))812 as the liquid lipid, Soybean phosphatidylcholine (Spc) and Solutol HS15 as the emulsifiers. The best formulation was optimized with a three-factor, three-level Box-Behnken design. Independent variables studied were the amount of the mixed lipid, the amount of the emulsifier mixture and lipid/drug ratio in the formulation. The dependent variables were the particle size, entrapment efficiency (EE) and drug loading (DL). Properties of NLC such as the morphology, particle size, zeta potential, EE, DL and drug release behavior were investigated, respectively. As a result, the designed nanoparticles showed nearly spherical particles with a mean particle size of 120 nm and -22.93 + or - 0.91 mV. The EE (%) and DL (%) could reach up to 89.18 + or - 0.28% and 1.46 + or - 0.05%, respectively. Differential scanning calorimetry (DSC) of Hup A loaded NLC indicated no tendency of recrystallisation. In vitro release studies showed a burst release at the initial stage and followed by a prolonged release of Hup A from NLC up to 96 h. The results suggest that the presented Hup A loaded NLC system is a potential delivery system for improving drug loading capacity and controlled drug release.


Subject(s)
Drug Carriers/chemistry , Lipids/chemistry , Nanostructures/chemistry , Neuroprotective Agents/chemistry , Sesquiterpenes/chemistry , Alkaloids , Calorimetry, Differential Scanning , Drug Carriers/chemical synthesis , Lipids/chemical synthesis , Microscopy, Electron, Transmission , Neuroprotective Agents/chemical synthesis , Particle Size , Sesquiterpenes/chemical synthesis
10.
Drug Dev Ind Pharm ; 36(7): 773-80, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20136496

ABSTRACT

BACKGROUND: The objective of this work was to study the preparation and characteristics of zedoary turmeric oil (ZTO), a traditional Chinese oily medicine, loaded with nanostructured lipid carriers (NLCs). METHOD: Aqueous dispersions of NLC were successfully prepared by melt-emulsification technique using Crodamol SS as the solid lipid, Miglyol 812N as the liquid oil, and soybean phosphatidylcholine (SbPC) as the emulsifier. Properties of NLC such as the particle size and its distribution, the transmission electron microscope (TEM), drug entrapment efficiency (EE), and drug release behavior were investigated, respectively. The Germacrone blood concentration after intravenous administration of ZTO-NLC was determined and compared with that of ZTO-injection. RESULT: As a result, the drug EEs were improved by adding the liquid lipid into the solid lipid of nanoparticles (SLNs). In vitro drug release experiments indicated that the prepared NLC could enhance the drug release rate over the SLN, and the drug release rate could be adjusted by the liquid lipid content in lipid nanospheres. X-ray and differential scanning calorimetry (DSC) measurements revealed that imperfect crystallization occurred in the inner core of the NLC particles. CONCLUSION: The results suggest that the presented NLC system might be a promising intravenous dosage form of water-insoluble oily drugs.


Subject(s)
Curcuma , Drug Carriers , Drugs, Chinese Herbal , Lipids , Nanoparticles/chemistry , Nanostructures/chemistry , Plant Oils , Antineoplastic Agents/chemistry , Curcuma/chemistry , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Drug Compounding , Drug Stability , Emulsions , Lipids/chemical synthesis , Lipids/chemistry , Nanotechnology , Particle Size , Plant Oils/chemistry , Surface Properties , Technology, Pharmaceutical , X-Ray Diffraction
11.
Sheng Wu Gong Cheng Xue Bao ; 23(2): 246-51, 2007 Mar.
Article in Chinese | MEDLINE | ID: mdl-17460896

ABSTRACT

The aim of this article is to provide methods for the isolation and identification of pancreatic stem cells and cell source for research and therapy of diabetes. ICCs were isolated by collagenase IV digesting and then cultured; epithelial cells were purified from monolayer cultured ICCs. The growth curve of the epithelial cells was measured by MTT. The expression of molecular markers in the cells was identified by immunohistochemical staining. The surface markers in the epithelial cells were analyzed by FACS. Epithelial cells were purified from isolated human fetal ICCs and passaged 40 times, and 10(6) - 10(8) cells were cryopreservated per passage. The growth curve demonstrated that the epithelial cells proliferated rapidly. The epithelial cells expressed PDX-1, PCNA, CK-7, CK-19, Nestin, Glut2, and Vimentin, but Insulin was undetected. The cells expressed CD29, CD44, and CD166, but did not express CD11a, CD14, CD34, CD45, CD90, CD105, and CD117. Taken together, these results indicate that self-renewable epithelial cells can be isolated and purified from human fetal pancreas. These also show that the epithelial cells originate from ducts and have the characteristics of pancreatic stem cells.


Subject(s)
Cell Proliferation , Epithelial Cells/cytology , Stem Cells/cytology , Cell Culture Techniques , Cell Separation , Cell Survival , Cells, Cultured , Epithelial Cells/metabolism , Fetus , Flow Cytometry , Homeodomain Proteins/analysis , Humans , Hyaluronan Receptors/analysis , Immunohistochemistry , Integrin beta1/analysis , Islets of Langerhans , Proliferating Cell Nuclear Antigen/analysis , Stem Cells/metabolism , Trans-Activators/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...